Loading...

Diane Havlir, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone415-476-4082 ext. 400
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Case Western Reserve University, Cleveland, OHFellow1990Fellowship, Infectious Diseases
    University of California, San Francisco, San Francisco, CAResidency 1987Internal Medicine Residency
    Duke University Medical School, Durham, NCM.D.1984Medicine
    St. Olaf College, Northfield, MinnesotaB.A.1980Chemistry/Biology
    Collapse Awards and Honors
    Duke University Medical School2017Duke Distinguished Alumni Award
    San Francisco General Hospital Foundation2015Heroes and Hearts Award
    Project Inform2014Thomas M Kelley Leadership Award
    University of California, San Francisco2014Chancellors Award for the Advancement of Women
    St. Olaf College2013Alumni Achievement Award
    University of California, San Francisco2014Pathways Mentorship Award
    Infectious Diseases Society of America2012Joseph E. Smadel Infectious Diseases Society of America Award
    International AIDS Conference2012United States Co-Chair for XIX International AIDS Conference
    Vanity Fair2012Vanity Fair Hall of Fame, “Pioneering leader in the fight against AIDS”
    University of California, San Francisco2010AIDS Research Institute Award for Outstanding Mentoring
    International AIDS Conference2010Scientific Chair for XVIII International AIDS Conference, Vienna
    University of California, San Francisco2009Pediatric Mentorship Award

    Collapse Overview 
    Collapse Overview
    The goal of my research is to develop therapeutic strategies to improve the lives of persons living with HIV, to reduce the global burden of HIV, and to advance public health in East Africa. Antiretroviral therapy is one of the greatest successes in medicine, yet we have not fully used it to eliminate HIV or tuberculosis (TB). My current areas of focus include 1) optimal HIV treatment approaches in the US with special attention to vulnerable populations in San Francisco, 2) optimal treatment strategies for HIV and TB, including new TB drug agents, 3) strategies to reduce the burden of HIV and malaria in children and pregnant women, and 4) testing of innovative approaches to early treatment of HIV using a community-based multi-disease approach following 320,000 persons in Uganda and Kenya to benefit the overall health, education and economics of communities in East Africa in the SEARCH study.

    Collapse Research 
    Collapse Research Activities and Funding
    UCSF-Gladstone Center for AIDS Research
    NIH/NIAID P30AI027763Oct 21, 2020 - Sep 14, 2007
    Role: Co-Investigator
    A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
    NIH/NIAID U01AI150510Sep 25, 2020 - Jun 30, 2025
    Role: Principal Investigator
    San Francisco Bay Clinical Trials Unit
    NIH/NIAID UM1AI069496Jun 15, 2020 - Nov 30, 2020
    Role: Co-Principal Investigator
    Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN)
    NIH/NICHD UG3HD096915Sep 1, 2018 - Aug 31, 2020
    Role: Principal Investigator
    Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
    NIH/NIAID R01AI125000Dec 14, 2016 - Nov 30, 2021
    Role: Principal Investigator
    Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)
    NIH/NIAID U01AI099959Jul 1, 2012 - Jun 30, 2017
    Role: Principal Investigator
    Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa
    NIH/NICHD P01HD059454Aug 1, 2008 - Jun 30, 2018
    Role: Principal Investigator
    UCSF HIV Clinical Trials Unit
    NIH/NIAID U01AI069502Jan 1, 2007 - Nov 30, 2013
    Role: Principal Investigator
    UCSF HIV Clinical Trials Unit
    NIH/NIAID UM1AI069502Jan 1, 2007 - Nov 30, 2013
    Role: Principal Investigator
    Training in HIV Translational Research
    NIH/NIAID T32AI060530Sep 5, 2005 - Jul 31, 2021
    Role: Principal Investigator
    Clinical Studies of Interactions Between HIV and Malaria
    NIH/NIAID U01AI062677Sep 30, 2004 - May 31, 2010
    Role: Principal Investigator
    Therapeutic Strategies for HIV Disease
    NIH/NIAID K24AI051982Apr 15, 2002 - Mar 31, 2014
    Role: Principal Investigator
    Center for AIDS Research
    NIH/NIAID P30AI036214Apr 1, 1997 - May 31, 2012
    Role: Co-Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000827Jan 27, 1997 - Nov 30, 2010
    Role: Co-Investigator
    SAN DIEGO AIDS CLINICAL TRIAL UNIT
    NIH/NIAID U01AI027670Jun 30, 1986 - Mar 31, 1992
    Role: Co-Principal Investigator
    ADULT AIDS CLINICAL TRIALS UNIT
    NIH/NIAID U01AI027663Jun 30, 1986 - Jun 30, 1991
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. AIDS. 2020 12 01; 34(15):2328-2331. Spinelli MA, Hickey MD, Glidden DV, Nguyen JQ, Oskarsson JJ, Havlir D, Gandhi M. PMID: 32910069.
      View in: PubMed   Mentions:    Fields:    
    2. Evaluation of a novel community-based COVID-19 'Test-to-Care' model for low-income populations. PLoS One. 2020; 15(10):e0239400. Kerkhoff AD, Sachdev D, Mizany S, Rojas S, Gandhi M, Peng J, Black D, Jones D, Rojas S, Jacobo J, Tulier-Laiwa V, Petersen M, Martinez J, Chamie G, Havlir DV, Marquez C. PMID: 33035216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    3. Piperaquine exposure is altered by pregnancy, HIV and nutritional status in Ugandan women. Antimicrob Agents Chemother. 2020 Oct 05. Hughes E, Imperial M, Wallender E, Kajubi R, Huang L, Jagannathan P, Zhang N, Kakuru A, Natureeba P, Mwima MW, Muhindo M, Mwebaza N, Clark TD, Opira B, Nakalembe M, Havlir D, Kamya M, Rosenthal PJ, Dorsey G, Aweeka F, Savic RM. PMID: 33020153.
      View in: PubMed   Mentions:    Fields:    
    4. Generation of a malaria negative Ugandan birth weight standard for the diagnosis of small for gestational age. PLoS One. 2020; 15(10):e0240157. Zakama AK, Weekes T, Kajubi R, Kakuru A, Ategeka J, Kamya M, Muhindo MK, Havlir D, Jagannathan P, Dorsey G, Gaw SL. PMID: 33007041.
      View in: PubMed   Mentions:    Fields:    
    5. Improved Viral Suppression with Streamlined Care in the SEARCH Study. . 2020 Sep 24. Hickey MD, Ayieko J, Kwarisiima D, Opel FJ, Owaraganise A, Balzer LB, Chamie G, Jain V, Peng J, Camlin C, Charlebois ED, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV. PMID: 32991337.
      View in: PubMed   Mentions:
    6. Far from MCAR: Obtaining Population-level Estimates of HIV Viral Suppression. Epidemiology. 2020 Sep; 31(5):620-627. Balzer LB, Ayieko J, Kwarisiima D, Chamie G, Charlebois ED, Schwab J, van der Laan MJ, Kamya MR, Havlir DV, Petersen ML. PMID: 32452912.
      View in: PubMed   Mentions:    Fields:    
    7. SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco. Clin Infect Dis. 2020 Aug 21. Chamie G, Marquez C, Crawford E, Peng J, Petersen M, Schwab D, Schwab J, Martinez J, Es DJ, Black D, Gandhi M, Kerkhoff AD, Jain V, Sergi F, Jacobo J, Rojas S, Tulier-Laiwa V, Gallardo-Brown T, Appa A, Chiu C, Rodgers M, Hackett J, Kistler A, Hao S, Kamm J, Dynerman D, Batson J, Greenhouse B, DeRisi J, Havlir DV. PMID: 32821935.
      View in: PubMed   Mentions: 3     Fields:    
    8. Understanding preferences for HIV care among patients experiencing homelessness or unstable-housing: A discrete choice experiment. . 2020 Aug 18. Conte M, Eshun-Wilson I, Geng E, Imbert E, Hickey MD, Havlir D, Gandhi M, Clemenzi-Allen A. PMID: 32826563.
      View in: PubMed   Mentions:
    9. Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community. medRxiv. 2020 Aug 17. Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu CY, Havlir D, Greenhouse B. PMID: 32839781.
      View in: PubMed   Mentions:
    10. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial. BMC Med. 2020 Aug 10; 18(1):207. Kakuru A, Jagannathan P, Kajubi R, Ochieng T, Ochokoru H, Nakalembe M, Clark TD, Ruel T, Staedke SG, Chandramohan D, Havlir DV, Kamya MR, Dorsey G. PMID: 32772921.
      View in: PubMed   Mentions:    Fields:    
    11. Gravidity-dependent associations between interferon response and birth weight in placental malaria. Malar J. 2020 Aug 05; 19(1):280. Quanquin NM, Barres LG, Aliyari SR, Day NT, Gerami H, Fisher SJ, Kakuru A, Kamya MR, Havlir DV, Feeney M, Dorsey G, Cheng G, Gaw SL. PMID: 32758231.
      View in: PubMed   Mentions:    Fields:    
    12. Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study. Curr HIV/AIDS Rep. 2020 08; 17(4):315-323. Chamie G, Hickey MD, Kwarisiima D, Ayieko J, Kamya MR, Havlir DV. PMID: 32507985.
      View in: PubMed   Mentions:    Fields:    
    13. Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial. AIDS. 2020 07 15; 34(9):1407-1415. Kabami J, Balzer LB, Saddiki H, Ayieko J, Kwarisiima D, Atukunda M, Charlebois ED, Clark TD, Koss CA, Ruel T, Bukusi EA, Cohen CR, Musoke P, Petersen ML, Havlir DV, Kamya MR, Chamie G. PMID: 32472768.
      View in: PubMed   Mentions:    Fields:    
    14. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study. AIDS Behav. 2020 Jul; 24(7):2149-2162. Camlin CS, Koss CA, Getahun M, Owino L, Itiakorit H, Akatukwasa C, Maeri I, Bakanoma R, Onyango A, Atwine F, Ayieko J, Kabami J, Mwangwa F, Atukunda M, Owaraganise A, Kwarisiima D, Sang N, Bukusi EA, Kamya MR, Petersen ML, Cohen CR, Charlebois ED, Havlir DV. PMID: 31955361.
      View in: PubMed   Mentions: 1     Fields:    
    15. The impact of gravidity, symptomatology and timing of infection on placental malaria. Malar J. 2020 Jun 24; 19(1):227. Tran EE, Cheeks ML, Kakuru A, Muhindo MK, Natureeba P, Nakalembe M, Ategeka J, Nayebare P, Kamya M, Havlir D, Feeney ME, Dorsey G, Gaw SL. PMID: 32580739.
      View in: PubMed   Mentions: 1     Fields:    
    16. Improving Care Outcomes for PLWH Experiencing Homelessness and Unstable Housing: a Synthetic Review of Clinic-Based Strategies. Curr HIV/AIDS Rep. 2020 06; 17(3):259-267. Clemenzi-Allen AA, Hickey M, Conte M, Das D, Geng E, Riley E, Havlir D, Gandhi M, Imbert E. PMID: 32382919.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Virtual CROI 2020: Tuberculosis and Coinfections In HIV Infection. Top Antivir Med. 2020 Jun; 28(2):455-458. Kerkhoff AD, Havlir DV. PMID: 32886465.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    18. SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures. medRxiv. 2020 May 30. Appa A, Chamie G, Sawyer A, Baltzell K, Dippel K, Ribeiro S, Duarte E, Vinden J, Consortium C, Kramer-Feldman J, Rahdari S, MacIntosh D, Nicholson K, Im J, Havlir D, Greenhouse B. PMID: 32511482.
      View in: PubMed   Mentions:
    19. Screening for Covid-19 in Skilled Nursing Facilities. Reply. N Engl J Med. 2020 07 09; 383(2):192-193. Gandhi M, Yokoe DS, Havlir DV. PMID: 32469484.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    20. A pilot randomized trial of incentive strategies to promote HIV retesting in rural Uganda. PLoS One. 2020; 15(5):e0233600. Chamie G, Ndyabakira A, Marson KG, Emperador DM, Kamya MR, Havlir DV, Kwarisiima D, Thirumurthy H. PMID: 32470089.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    21. Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. Clin Infect Dis. 2020 May 25. Bacon O, Chin J, Cohen SE, Sachdev D, Coffey S, Scheer S, Hessol NA, Buchbinder S, Havlir DV, Hsu L. PMID: 32449916.
      View in: PubMed   Mentions: 1     Fields:    
    22. The Impact of Control Interventions on Malaria Burden in Young Children in a Historically High-Transmission District of Uganda: A Pooled Analysis of Cohort Studies from 2007 to 2018. Am J Trop Med Hyg. 2020 Aug; 103(2):785-792. Kamya MR, Kakuru A, Muhindo M, Arinaitwe E, Nankabirwa JI, Rek J, Bigira V, Kapisi J, Wanzira H, Achan J, Natureeba P, Gasasira A, Havlir D, Jagannathan P, Rosenthal PJ, Rodriguez-Barraquer I, Dorsey G. PMID: 32431280.
      View in: PubMed   Mentions:    Fields:    
    23. Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy. Curr Dev Nutr. 2020 May; 4(5):nzaa075. Finkelstein JL, Herman HS, Plenty A, Mehta S, Natureeba P, Clark TD, Kamya MR, Ruel T, Charlebois ED, Cohan D, Havlir D, Young SL. PMID: 32440638.
      View in: PubMed   Mentions:
    24. Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19. N Engl J Med. 2020 05 28; 382(22):2158-2160. Gandhi M, Yokoe DS, Havlir DV. PMID: 32329972.
      View in: PubMed   Mentions: 113     Fields:    Translation:CellsPHPublic Health
    25. The Time for Universal Masking of the Public for Coronavirus Disease 2019 Is Now. Open Forum Infect Dis. 2020 Apr; 7(4):ofaa131. Gandhi M, Havlir D. PMID: 32346544.
      View in: PubMed   Mentions:
    26. The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study. PLoS One. 2020; 15(3):e0229649. Muiru AN, Charlebois ED, Balzer LB, Kwarisiima D, Elly A, Black D, Okiror S, Kabami J, Atukunda M, Snyman K, Petersen M, Kamya M, Havlir D, Estrella MM, Hsu CY. PMID: 32130245.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Putting women in the centre of the global HIV response is key to achieving epidemic control! J Int AIDS Soc. 2020 03; 23(3):e25473. Abdool Karim Q, Havlir D, Phanuphak N. PMID: 32142213.
      View in: PubMed   Mentions:    Fields:    
    28. Men's Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda. AIDS Behav. 2020 Mar; 24(3):967-974. Ndyabakira A, Chamie G, Emperador D, Marson K, Kamya MR, Havlir DV, Kwarisiima D, Thirumurthy H. PMID: 31073946.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. AIDS. 2020 03 01; 34(3):405-413. Puryear SB, Balzer LB, Ayieko J, Kwarisiima D, Hahn JA, Charlebois ED, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Petersen ML, Havlir DV, Chamie G. PMID: 31725431.
      View in: PubMed   Mentions: 1     Fields:    
    30. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020 04; 7(4):e249-e261. Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, Atukunda M, Mwangwa F, Peng J, Mwinike Y, Owaraganise A, Chamie G, Jain V, Sang N, Olilo W, Brown LB, Marquez C, Zhang K, Ruel TD, Camlin CS, Rooney JF, Black D, Clark TD, Gandhi M, Cohen CR, Bukusi EA, Petersen ML, Kamya MR, Havlir DV. PMID: 32087152.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    31. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines. Lancet HIV. 2020 03; 7(3):e193-e200. Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, Wensing A, Lundgren JD, Pillay D, Mellors J, Cambiano V, Jahn A, Apollo T, Mugurungi O, Ripin D, Da Silva J, Raizes E, Ford N, Siberry GK, Gupta RK, Barnabas R, Revill P, Cohn J, Calmy A, Bertagnolio S. PMID: 32035041.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? J Int AIDS Soc. 2020 02; 23(2):e25455. Havlir D, Lockman S, Ayles H, Larmarange J, Chamie G, Gaolathe T, Iwuji C, Fidler S, Kamya M, Floyd S, Moore J, Hayes R, Petersen M, Dabis F. PMID: 32091179.
      View in: PubMed   Mentions: 1     Fields:    
    33. Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa. AIDS. 2020 02 01; 34(2):311-315. Lesosky M, Raboud JM, Glass T, Brummel SS, Ciaranello AL, Currier JS, Essajee S, Havlir DV, Koss CA, Ogwu A, Shapiro RL, Abrams EJ, Myer L. PMID: 31634186.
      View in: PubMed   Mentions: 2     Fields:    
    34. The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda. PLoS One. 2020; 15(1):e0228102. Marquez C, Atukunda M, Balzer LB, Chamie G, Kironde J, Ssemmondo E, Ruel TD, Mwangwa F, Tram KH, Clark TD, Kwarisiima D, Petersen M, Kamya MR, Charlebois ED, Havlir DV. PMID: 31995631.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation. PLoS One. 2020; 15(1):e0222801. Heller DJ, Balzer LB, Kazi D, Charlebois ED, Kwarisiima D, Mwangwa F, Jain V, Kotwani P, Chamie G, Cohen CR, Clark TD, Ayieko J, Byonanabye DM, Petersen M, Kamya MR, Havlir D, Kahn JG. PMID: 31940346.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    36. The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda. . 2020 01 01; 83(1):9-15. Brown LB, Balzer LB, Kabami J, Kwarisiima D, Sang N, Ayieko J, Chen Y, Chamie G, Charlebois ED, Camlin CS, Cohen CR, Bukusi E, Kamya MR, Moody J, Havlir DV, Petersen ML. PMID: 31809357.
      View in: PubMed   Mentions:
    37. The Golden Compass Program: Overview of the Initial Implementation of a Comprehensive Program for Older Adults Living with HIV. J Int Assoc Provid AIDS Care. 2020 Jan-Dec; 19:2325958220935267. Greene M, Myers J, Tan JY, Blat C, O'Hollaren A, Quintanilla F, Hsue P, Shiels M, Hicks ML, Olson B, Grochowski J, Oskarsson J, Havlir D, Gandhi M. PMID: 32715875.
      View in: PubMed   Mentions:    Fields:    
    38. Leveraging incentives to increase HIV testing uptake among men: qualitative insights from rural Uganda. BMC Public Health. 2019 Dec 30; 19(1):1763. Ndyabakira A, Getahun M, Byamukama A, Emperador D, Kabageni S, Marson K, Kwarisiima D, Chamie G, Thirumurthy H, Havlir D, Kamya MR, Camlin CS. PMID: 31888589.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    39. Getting to Zero San Francisco: A Collective Impact Approach. . 2019 12; 82 Suppl 3:S176-S182. Buchbinder SP, Havlir DV. PMID: 31764252.
      View in: PubMed   Mentions:
    40. Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya. . 2019 12 01; 82(4):e50-e53. Olilo WA, Petersen ML, Koss CA, Wafula E, Kwarisiima D, Kadede K, Clark TD, Cohen CR, Bukusi EA, Kamya MR, Charlebois ED, Havlir DV, Ayieko J. PMID: 31490343.
      View in: PubMed   Mentions:
    41. Machine learning to identify persons at high-risk of HIV acquisition in rural Kenya and Uganda. Clin Infect Dis. 2019 Nov 07. Balzer LB, Havlir DV, Kamya MR, Chamie G, Charlebois ED, Clark TD, Koss CA, Kwarisiima D, Ayieko J, Sang N, Kabami J, Atukunda M, Jain V, Camlin CS, Cohen CR, Bukusi EA, van der Laan M, Petersen ML. PMID: 31697383.
      View in: PubMed   Mentions: 4     Fields:    
    42. Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial. Curr Opin HIV AIDS. 2019 11; 14(6):449-454. Chamie G, Kamya MR, Petersen ML, Havlir DV. PMID: 31589172.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    43. Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a US city. AIDS. 2019 09 01; 33(11):1789-1794. Spinelli MA, Hessol NA, Schwarcz S, Hsu L, Parisi MK, Pipkin S, Scheer S, Havlir D, Buchbinder SP. PMID: 31259765.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Global HIV Treatment - Turning Headwinds to Tailwinds. N Engl J Med. 2019 08 29; 381(9):873-874. Havlir DV, Doherty MC. PMID: 31339675.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    45. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. N Engl J Med. 2019 07 18; 381(3):219-229. Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J, Kabami J, Sang N, Liegler T, Chamie G, Camlin CS, Jain V, Kadede K, Atukunda M, Ruel T, Shade SB, Ssemmondo E, Byonanebye DM, Mwangwa F, Owaraganise A, Olilo W, Black D, Snyman K, Burger R, Getahun M, Achando J, Awuonda B, Nakato H, Kironde J, Okiror S, Thirumurthy H, Koss C, Brown L, Marquez C, Schwab J, Lavoy G, Plenty A, Mugoma Wafula E, Omanya P, Chen YH, Rooney JF, Bacon M, van der Laan M, Cohen CR, Bukusi E, Kamya MR, Petersen M. PMID: 31314966.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    46. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. Lancet Infect Dis. 2019 09; 19(9):962-972. Muhindo MK, Jagannathan P, Kakuru A, Opira B, Olwoch P, Okiring J, Nalugo N, Clark TD, Ruel T, Charlebois E, Feeney ME, Havlir DV, Dorsey G, Kamya MR. PMID: 31307883.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    47. Ending AIDS in the United States-If Not Now, When? JAMA Intern Med. 2019 Jun 11. Havlir DV, Buchbinder SP. PMID: 31184750.
      View in: PubMed   Mentions: 1     Fields:    
    48. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda. AIDS Care. 2020 01; 32(1):119-127. Tram KH, Mwangwa F, Chamie G, Atukunda M, Owaraganise A, Ayieko J, Jain V, Clark TD, Kwarisiima D, Petersen ML, Kamya MR, Charlebois ED, Havlir DV, Marquez C. PMID: 31181961.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa. Health Place. 2019 05; 57:339-351. Camlin CS, Akullian A, Neilands TB, Getahun M, Bershteyn A, Ssali S, Geng E, Gandhi M, Cohen CR, Maeri I, Eyul P, Petersen ML, Havlir DV, Kamya MR, Bukusi EA, Charlebois ED. PMID: 31152972.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    50. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2019 05 17; 68(11):1877-1886. Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. PMID: 30219823.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    51. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public Health. 2019 May 06; 19(1):511. Kwarisiima D, Atukunda M, Owaraganise A, Chamie G, Clark T, Kabami J, Jain V, Byonanebye D, Mwangwa F, Balzer LB, Charlebois E, Kamya MR, Petersen M, Havlir DV, Brown LB. PMID: 31060545.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    52. Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole. Sci Rep. 2019 05 01; 9(1):6758. McDonald CR, Weckman AM, Conroy AL, Olwoch P, Natureeba P, Kamya MR, Havlir DV, Dorsey G, Kain KC. PMID: 31043691.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    53. A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome. Int J Infect Dis. 2019 Jul; 84:30-38. Silva CAM, Graham B, Webb K, Ashton LV, Harton M, Luetkemeyer AF, Bokatzian S, Almubarak R, Mahapatra S, Hovind L, Kendall MA, Havlir D, Belisle JT, De Groote MA. PMID: 31009738.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya. . 2019 04 01; 80(4):414-422. Ayieko J, Petersen ML, Charlebois ED, Brown LB, Clark TD, Kwarisiima D, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Van Rie A. PMID: 30807481.
      View in: PubMed   Mentions:
    55. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS. 2019 04 01; 33(5):825-832. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. PMID: 30882490.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    56. CROI 2019: complications and coinfections in HIV infection. Top Antivir Med. 2019 Apr; 27(1):34-40. Currier JS, Havlir DV. PMID: 31137001.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda. J Int AIDS Soc. 2019 04; 22(4):e25276. Mayer CM, Owaraganise A, Kabami J, Kwarisiima D, Koss CA, Charlebois ED, Kamya MR, Petersen ML, Havlir DV, Jewell BL. PMID: 31037845.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    58. Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort. Open Forum Infect Dis. 2019 May; 6(5):ofz148. Clemenzi-Allen A, Neuhaus J, Geng E, Sachdev D, Buchbinder S, Havlir D, Gandhi M, Christopoulos K. PMID: 31139668.
      View in: PubMed   Mentions:
    59. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Lancet. 2019 Apr 06; 393(10179):1428-1439. Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, Opira B, Ochokoru H, Ategeka J, Nayebare P, Clark TD, Havlir DV, Kamya MR, Dorsey G. PMID: 30910321.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    60. Closing the gap: A novel metric of change in performance. East Afr J Appl Health Monitor Eval. 2019 Feb; 2019(3). Katuramu R, Wallenta J, Semitala FC, Amanyire G, Kampiire L, Namusobya J, Kamya MR, Havlir D, Glidden DV, Geng E. PMID: 32817932.
      View in: PubMed   Mentions:
    61. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda. Antimicrob Agents Chemother. 2019 02; 63(2). Wallender E, Zhang N, Conrad M, Kakuru A, Muhindo M, Tumwebaze P, Kajubi R, Mota D, Legac J, Jagannathan P, Havlir D, Kamya M, Dorsey G, Aweeka F, Rosenthal PJ, Savic RM. PMID: 30530597.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis. PLoS One. 2019; 14(1):e0210126. Brown LB, Getahun M, Ayieko J, Kwarisiima D, Owaraganise A, Atukunda M, Olilo W, Clark T, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV, Camlin CS. PMID: 30673744.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    63. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial. Lancet HIV. 2019 03; 6(3):e155-e163. Thirumurthy H, Ndyabakira A, Marson K, Emperador D, Kamya M, Havlir D, Kwarisiima D, Chamie G. PMID: 30660594.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    64. Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco. PLoS One. 2018; 13(12):e0208486. Greene ML, Tan JY, Weiser SD, Christopoulos K, Shiels M, O'Hollaren A, Mureithi E, Meissner L, Havlir D, Gandhi M. PMID: 30517193.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    65. Mobile, Population-wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda. Pediatr Infect Dis J. 2018 12; 37(12):1279-1281. Ayieko J, Chamie G, Balzer L, Kwarisiima D, Kabami J, Sang N, Cohen CR, Bukusi EA, Clark TD, Plenty A, Charlebois ED, Petersen M, Kamya M, Havlir DV, Ruel T. PMID: 30199482.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    66. Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. Lancet HIV. 2018 Nov 29. Cohen SE, Sachdev D, Lee SA, Scheer S, Bacon O, Chen MJ, Okochi H, Anderson PL, Kearney MF, Coffey S, Scott H, Grant RM, Havlir D, Gandhi M. PMID: 30503324.
      View in: PubMed   Mentions: 11     Fields:    
    67. Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. Lancet HIV. 2019 Feb; 6(2):e116-e127. Phillips AN, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren JD, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta RK, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A. PMID: 30503325.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    68. Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda. Clin Infect Dis. 2018 11 28; 67(12):1853-1860. Koss CA, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Balzer LB, Plenty A, Sang N, Kabami J, Ruel TD, Black D, Camlin CS, Cohen CR, Bukusi EA, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV. PMID: 29741594.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    69. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys. AIDS. 2018 09 24; 32(15):2179-2188. Shade SB, Osmand T, Luo A, Aine R, Assurah E, Mwebaza B, Mwai D, Owaraganise A, Mwangwa F, Ayieko J, Black D, Brown LB, Clark TD, Kwarisiima D, Thirumurthy H, Cohen CR, Bukusi EA, Charlebois ED, Balzer L, Kamya MR, Petersen ML, Havlir DV, Jain V. PMID: 30134294.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    70. Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine. Clin Infect Dis. 2018 09 14; 67(7):1079-1088. Savic RM, Jagannathan P, Kajubi R, Huang L, Zhang N, Were M, Kakuru A, Muhindo MK, Mwebaza N, Wallender E, Clark TD, Opira B, Kamya M, Havlir DV, Rosenthal PJ, Dorsey G, Aweeka FT. PMID: 29547881.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One. 2018; 13(8):e0202990. Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED, Petersen ML, Clark TD, Kamya MR, Cohen CR, Bukusi EA, Havlir DV, Camlin CS. PMID: 30161172.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    72. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet. 2018 07 28; 392(10144):312-358. Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, Kamarulzaman A, Kasaie P, Kazatchkine M, Kilonzo N, Klag M, Klein M, Lewin SR, Luo C, Makofane K, Martin NK, Mayer K, Millett G, Ntusi N, Pace L, Pike C, Piot P, Pozniak A, Quinn TC, Rockstroh J, Ratevosian J, Ryan O, Sippel S, Spire B, Soucat A, Starrs A, Strathdee SA, Thomson N, Vella S, Schechter M, Vickerman P, Weir B, Beyrer C. PMID: 30032975.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    73. Comparative effectiveness of novel nonmonetary incentives to promote HIV testing. AIDS. 2018 07 17; 32(11):1443-1451. Chamie G, Schaffer EM, Ndyabakira A, Emperador DM, Kwarisiima D, Camlin CS, Havlir DV, Kahn JG, Kamya MR, Thirumurthy H. PMID: 29683850.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    74. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002606. Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, Opira B, Olwoch P, Nankya F, Ssewanyana I, Tetteh K, Drakeley C, Beeson J, Reiling L, Clark TD, Rodriguez-Barraquer I, Greenhouse B, Wallender E, Aweeka F, Prahl M, Charlebois ED, Feeney ME, Havlir DV, Kamya MR, Dorsey G. PMID: 30016328.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    75. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial. PLoS One. 2018; 13(6):e0198912. Jakubowski A, Snyman K, Kwarisiima D, Sang N, Burger R, Balzer L, Clark T, Chamie G, Shade S, Cohen C, Bukusi E, Charlebois E, Kamya M, Petersen M, Havlir D, Thirumurthy H. PMID: 29944678.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    76. Effect of a Patient-Centered Phone Call by a Clinical Officer at Time of HIV Testing on Linkage to Care in Rural Kenya. Open Forum Infect Dis. 2018 Jun 01; 5(6):ofy126. Ayieko J, Petersen ML, van Rie A, Wafula E, Opudo W, Clark TD, Kamya MR, Balzer LB, Cohen CR, Bukusi EA, Charlebois ED, Havlir DV. PMID: 29977971.
      View in: PubMed   Mentions:
    77. CROI 2018: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2018 May; 26(1):22-29. Currier JS, Havlir DV. PMID: 29727294.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    78. Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells. Pathog Immun. 2018; 3(1):46-62. Sattler FR, Chelliah D, Wu X, Sanchez A, Kendall MA, Hogg E, Lagat D, Lalloo U, Veloso V, Havlir DV, Landay A. PMID: 29770360.
      View in: PubMed   Mentions:
    79. Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the "Getting to Zero" Era. Clin Infect Dis. 2018 03 19; 66(7):1027-1034. Scheer S, Hsu L, Schwarcz S, Pipkin S, Havlir D, Buchbinder S, Hessol NA. PMID: 29099913.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    80. Degree of Housing Instability Shows Independent "Dose-Response" With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus. Open Forum Infect Dis. 2018 Mar; 5(3):ofy035. Clemenzi-Allen A, Geng E, Christopoulos K, Hammer H, Buchbinder S, Havlir D, Gandhi M. PMID: 29577059.
      View in: PubMed   Mentions:
    81. Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus-Infected Women Receiving Efavirenz. J Infect Dis. 2018 03 05; 217(6):964-972. Wallender E, Vucicevic K, Jagannathan P, Huang L, Natureeba P, Kakuru A, Muhindo M, Nakalembe M, Havlir D, Kamya M, Aweeka F, Dorsey G, Rosenthal PJ, Savic RM. PMID: 29272443.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    82. Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda. PLoS One. 2018; 13(2):e0192666. Chamie G, Kato-Maeda M, Emperador DM, Wandera B, Mugagga O, Crandall J, Janes M, Marquez C, Kamya MR, Charlebois ED, Havlir DV. PMID: 29438413.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    83. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa. J Int AIDS Soc. 2018 01; 21(1). Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H, Floyd S, Havlir D, Kamya M, Lebelonyane R, Mills LA, Okello V, Petersen M, Pillay D, Sabapathy K, Wirth K, Orne-Gliemann J, Dabis F. PMID: 29314658.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    84. Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis. J Infect Dis. 2017 12 19; 216(12):1541-1549. Roh ME, Shiboski S, Natureeba P, Kakuru A, Muhindo M, Ochieng T, Plenty A, Koss CA, Clark TD, Awori P, Nakalambe M, Cohan D, Jagannathan P, Gosling R, Havlir DV, Kamya MR, Dorsey G. PMID: 29029337.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    85. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care. . 2017 Dec 15; 76(5):e115-e117. Tram KH, Mwangwa F, Atukunda M, Owaraganise A, Ayieko J, Plenty A, Kwariisima D, Clark TD, Petersen ML, Charlebois ED, Kamya MR, Chamie G, Havlir DV, Marquez C. PMID: 28885271.
      View in: PubMed   Mentions:
    86. Redemption of the "spoiled identity:" the role of HIV-positive individuals in HIV care cascade interventions. J Int AIDS Soc. 2017 12; 20(4). Camlin CS, Charlebois ED, Geng E, Semitala F, Wallenta J, Getahun M, Kampiire L, Bukusi EA, Sang N, Kwarisiima D, Clark TD, Petersen ML, Kamya MR, Havlir DV. PMID: 29210185.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and Kenya. J Clin Tuberc Other Mycobact Dis. 2017 Dec; 9:24-29. Mwangwa F, Chamie G, Kwarisiima D, Ayieko J, Owaraganise A, Ruel TD, Plenty A, Tram KH, Clark TD, Cohen CR, Bukusi EA, Petersen M, Kamya MR, Charlebois ED, Havlir DV, Marquez C. PMID: 29291251.
      View in: PubMed   Mentions:
    88. Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry. J Int AIDS Soc. 2017 12; 20(4). Semitala FC, Camlin CS, Wallenta J, Kampiire L, Katuramu R, Amanyire G, Namusobya J, Chang W, Kahn JG, Charlebois ED, Havlir DV, Kamya MR, Geng EH. PMID: 29206357.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    89. Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study. Lancet HIV. 2018 03; 5(3):e146-e154. Phillips AN, Cambiano V, Nakagawa F, Revill P, Jordan MR, Hallett TB, Doherty M, De Luca A, Lundgren JD, Mhangara M, Apollo T, Mellors J, Nichols B, Parikh U, Pillay D, Rinke de Wit T, Sigaloff K, Havlir D, Kuritzkes DR, Pozniak A, van de Vijver D, Vitoria M, Wainberg MA, Raizes E, Bertagnolio S. PMID: 29174084.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    90. Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda. J Infect Dis. 2017 11 15; 216(8):1008-1017. Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ. PMID: 28968782.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    91. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Am J Obstet Gynecol. 2017 12; 217(6):684.e1-684.e17. Conroy AL, McDonald CR, Gamble JL, Olwoch P, Natureeba P, Cohan D, Kamya MR, Havlir DV, Dorsey G, Kain KC. PMID: 29031892.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    92. Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes. Malar J. 2017 10 05; 16(1):400. Kapisi J, Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Ssekitoleko R, Olwoch P, Ategeka J, Nayebare P, Clark TD, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G, Gaw SL. PMID: 28982374.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    93. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya. . 2017 09 01; 76(1):e15-e18. Brown LB, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, Ruel T, Clark T, Black D, Chamie G, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED, Havlir DV. PMID: 28394821.
      View in: PubMed   Mentions:
    94. The science of rapid start-From the when to the how of antiretroviral initiation. PLoS Med. 2017 Jul; 14(7):e1002358. Geng EH, Havlir DV. PMID: 28742819.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    95. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. J Int AIDS Soc. 2017 07 21; 20(Suppl 4):21673. Kwarisiima D, Kamya MR, Owaraganise A, Mwangwa F, Byonanebye DM, Ayieko J, Plenty A, Black D, Clark TD, Nzarubara B, Snyman K, Brown L, Bukusi E, Cohen CR, Geng EH, Charlebois ED, Ruel TD, Petersen ML, Havlir D, Jain V. PMID: 28770596.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    96. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women. J Infect Dis. 2017 07 01; 216(1):29-35. Natureeba P, Kakuru A, Muhindo M, Ochieng T, Ategeka J, Koss CA, Plenty A, Charlebois ED, Clark TD, Nzarubara B, Nakalembe M, Cohan D, Rizzuto G, Muehlenbachs A, Ruel T, Jagannathan P, Havlir DV, Kamya MR, Dorsey G. PMID: 28329368.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    97. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa. JAMA. 2017 Jun 06; 317(21):2196-2206. Petersen M, Balzer L, Kwarsiima D, Sang N, Chamie G, Ayieko J, Kabami J, Owaraganise A, Liegler T, Mwangwa F, Kadede K, Jain V, Plenty A, Brown L, Lavoy G, Schwab J, Black D, van der Laan M, Bukusi EA, Cohen CR, Clark TD, Charlebois E, Kamya M, Havlir D. PMID: 28586888.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    98. Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. Clin Pharmacol Ther. 2017 Sep; 102(3):520-528. Kajubi R, Huang L, Jagannathan P, Chamankhah N, Were M, Ruel T, Koss CA, Kakuru A, Mwebaza N, Kamya M, Havlir D, Dorsey G, Rosenthal PJ, Aweeka FT. PMID: 28187497.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    99. CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment. Top Antivir Med. 2017 May/Jun; 25(2):77-83. Currier JS, Havlir DV. PMID: 28598792.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    100. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda. . 2017 Mar 01; 74(3):279-284. Koss CA, Natureeba P, Kwarisiima D, Ogena M, Clark TD, Olwoch P, Cohan D, Okiring J, Charlebois ED, Kamya MR, Havlir DV. PMID: 27828878.
      View in: PubMed   Mentions:
    101. Sex Disparity in Cord Blood FoxP3+ CD4 T Regulatory Cells in Infants Exposed to Malaria In Utero. Open Forum Infect Dis. 2017; 4(1):ofx022. Prahl M, Jagannathan P, McIntyre TI, Auma A, Wamala S, Nalubega M, Musinguzi K, Naluwu K, Sikyoma E, Budker R, Odorizzi P, Kakuru A, Havlir DV, Kamya MR, Dorsey G, Feeney ME. PMID: 28480292.
      View in: PubMed   Mentions:
    102. The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting. . 2017 Jan 01; 74(1):44-51. Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H. PMID: 27434707.
      View in: PubMed   Mentions:
    103. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis. Lancet HIV. 2017 03; 4(3):e122-e133. Jain V, Petersen ML, Liegler T, Byonanebye DM, Kwarisiima D, Chamie G, Sang N, Black D, Clark TD, Ladai A, Plenty A, Kabami J, Ssemmondo E, Bukusi EA, Cohen CR, Charlebois ED, Kamya MR, Havlir DV. PMID: 27989576.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    104. Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy. Pediatr Infect Dis J. 2016 12; 35(12):1329-1332. Achan J, Kakuru A, Ikilezi G, Mwangwa F, Plenty A, Charlebois E, Young S, Havlir D, Kamya M, Ruel T. PMID: 27580060.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. High levels of retention in care with streamlined care and universal test and treat in East Africa. AIDS. 2016 11 28; 30(18):2855-2864. Brown LB, Havlir DV, Ayieko J, Mwangwa F, Owaraganise A, Kwarisiima D, Jain V, Ruel T, Clark T, Chamie G, Bukusi EA, Cohen CR, Kamya MR, Petersen ML, Charlebois ED. PMID: 27603290.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    106. Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda. . 2016 Nov 01; 73(3):e46-e50. Ssemmondo E, Mwangwa F, Kironde JL, Kwarisiima D, Clark TD, Marquez C, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, Chamie G. PMID: 27741032.
      View in: PubMed   Mentions:
    107. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. . 2016 Nov 01; 73(3):e39-e45. Chang W, Chamie G, Mwai D, Clark TD, Thirumurthy H, Charlebois ED, Petersen M, Kabami J, Ssemmondo E, Kadede K, Kwarisiima D, Sang N, Bukusi EA, Cohen CR, Kamya M, Havlir DV, Kahn JG. PMID: 27741031.
      View in: PubMed   Mentions:
    108. Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting. Malar J. 2016 Oct 18; 15(1):500. Kakuru A, Natureeba P, Muhindo MK, Clark TD, Havlir DV, Cohan D, Dorsey G, Kamya MR, Ruel T. PMID: 27756308.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    109. Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation. Malar J. 2016 10 07; 15(1):497. Prahl M, Jagannathan P, McIntyre TI, Auma A, Farrington L, Wamala S, Nalubega M, Musinguzi K, Naluwu K, Sikyoma E, Budker R, Vance H, Odorizzi P, Nayebare P, Ategeka J, Kakuru A, Havlir DV, Kamya MR, Dorsey G, Feeney ME. PMID: 27717402.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    110. Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya. AIDS. 2016 09 10; 30(14):2121-6. Kadede K, Ruel T, Kabami J, Ssemmondo E, Sang N, Kwarisiima D, Bukusi E, Cohen CR, Liegler T, Clark TD, Charlebois ED, Petersen ML, Kamya MR, Havlir DV, Chamie G. PMID: 27258399.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    111. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016 11; 3(11):e539-e548. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, Charlebois E, Camlin C, Kahn J, Chang W, Glidden D, Kamya M, Havlir D, Geng E. PMID: 27658873.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    112. Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda. Malar J. 2016 Aug 26; 15(1):437. Muhindo MK, Kakuru A, Natureeba P, Awori P, Olwoch P, Ategeka J, Nayebare P, Clark TD, Muehlenbachs A, Roh M, Mpeka B, Greenhouse B, Havlir DV, Kamya MR, Dorsey G, Jagannathan P. PMID: 27566109.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    113. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016 09 01; 375(9):830-9. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR. PMID: 27424812.
      View in: PubMed   Mentions: 291     Fields:    Translation:HumansCells
    114. Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. PLoS One. 2016; 11(7):e0158262. Saharia KK, Petrovas C, Ferrando-Martinez S, Leal M, Luque R, Ive P, Luetkemeyer A, Havlir D, Koup RA. PMID: 27367521.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    115. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Nat Med. 2016 07; 22(7):807-11. Li P, Kaiser P, Lampiris HW, Kim P, Yukl SA, Havlir DV, Greene WC, Wong JK. PMID: 27294875.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    116. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda. PLoS One. 2016; 11(5):e0156309. Kwarisiima D, Balzer L, Heller D, Kotwani P, Chamie G, Clark T, Ayieko J, Mwangwa F, Jain V, Byonanebye D, Petersen M, Havlir D, Kamya MR. PMID: 27232186.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    117. CROI 2016: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2016 May-Jun; 24(1):38-46. Havlir DV, Currier JS. PMID: 27398861.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    118. Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda. Pediatr Infect Dis J. 2016 May; 35(5):524-9. Marquez C, Chamie G, Achan J, Luetkemeyer AF, Kyohere M, Okiring J, Dorsey G, Kamya MR, Charlebois ED, Havlir DV. PMID: 26771662.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    119. Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. N Engl J Med. 2016 Mar 10; 374(10):928-39. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Opira B, Olwoch P, Ategeka J, Nayebare P, Clark TD, Feeney ME, Charlebois ED, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G. PMID: 26962728.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    120. Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan Women. . 2016 Mar 01; 71(3):310-5. Koss CA, Natureeba P, Nyafwono D, Plenty A, Mwesigwa J, Nzarubara B, Clark TD, Ruel TD, Achan J, Charlebois ED, Cohan D, Kamya MR, Havlir DV, Young SL. PMID: 26397935.
      View in: PubMed   Mentions:
    121. Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda. J Infect Dis. 2016 06 15; 213(12):1971-8. Katrak S, Day N, Ssemmondo E, Kwarisiima D, Midekisa A, Greenhouse B, Kamya M, Havlir D, Dorsey G. PMID: 26908725.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    122. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clin Infect Dis. 2016 May 01; 62(9):1081-8. Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D. PMID: 26839383.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    123. A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. Lancet HIV. 2016 Mar; 3(3):e111-9. Chamie G, Clark TD, Kabami J, Kadede K, Ssemmondo E, Steinfeld R, Lavoy G, Kwarisiima D, Sang N, Jain V, Thirumurthy H, Liegler T, Balzer LB, Petersen ML, Cohen CR, Bukusi EA, Kamya MR, Havlir DV, Charlebois ED. PMID: 26939734.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansPHPublic Health
    124. Men "missing" from population-based HIV testing: insights from qualitative research. AIDS Care. 2016; 28 Suppl 3:67-73. Camlin CS, Ssemmondo E, Chamie G, El Ayadi AM, Kwarisiima D, Sang N, Kabami J, Charlebois E, Petersen M, Clark TD, Bukusi EA, Cohen CR, R Kamya M, Havlir D. PMID: 27421053.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    125. Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial. AIDS Care. 2016; 28 Suppl 3:90-8. Thirumurthy H, Jakubowski A, Camlin C, Kabami J, Ssemmondo E, Elly A, Mwai D, Clark T, Cohen C, Bukusi E, Kamya M, Petersen M, Havlir D, Charlebois ED. PMID: 27421056.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    126. "How can I tell?" Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV "test-and-treat" trial. AIDS Care. 2016; 28 Suppl 3:59-66. Maeri I, El Ayadi A, Getahun M, Charlebois E, Akatukwasa C, Tumwebaze D, Itiakorit H, Owino L, Kwarisiima D, Ssemmondo E, Sang N, Kabami J, Clark TD, Petersen M, Cohen CR, Bukusi EA, Kamya M, Havlir D, Camlin CS. PMID: 27421052.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    127. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. PLoS One. 2015; 10(12):e0143433. Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DV, Kahn JG. PMID: 26632823.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    128. "I Have Remained Strong Because of That Food": Acceptability and Use of Lipid-Based Nutrient Supplements Among Pregnant HIV-Infected Ugandan Women Receiving Combination Antiretroviral Therapy. AIDS Behav. 2015 Aug; 19(8):1535-47. Young S, Natamba B, Luwedde F, Nyafwono D, Okia B, Osterbauer B, Natureeba P, Johnson L, Michel C, Zheng A, Robine M, Achan J, Charlebois E, Cohan D, Havlir D. PMID: 25416075.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    129. Implementation challenges for long-acting antivirals as treatment. Curr Opin HIV AIDS. 2015 Jul; 10(4):282-9. Havlir D, Gandhi M. PMID: 26049955.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    130. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women. AIDS. 2015 Apr 24; 29(7):825-30. Koss CA, Natureeba P, Mwesigwa J, Cohan D, Nzarubara B, Bacchetti P, Horng H, Clark TD, Plenty A, Ruel TD, Achan J, Charlebois ED, Kamya MR, Havlir DV, Gandhi M. PMID: 25985404.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    131. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS One. 2015; 10(3):e0121290. Yukl SA, Shergill AK, Girling V, Li Q, Killian M, Epling L, Li P, Kaiser P, Haase A, Havlir DV, McQuaid K, Sinclair E, Wong JK. PMID: 25811360.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    132. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob Agents Chemother. 2015; 59(6):3018-30. Tumwebaze P, Conrad MD, Walakira A, LeClair N, Byaruhanga O, Nakazibwe C, Kozak B, Bloome J, Okiring J, Kakuru A, Bigira V, Kapisi J, Legac J, Gut J, Cooper RA, Kamya MR, Havlir DV, Dorsey G, Greenhouse B, Nsobya SL, Rosenthal PJ. PMID: 25753626.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    133. The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, Uganda. Pediatr Infect Dis J. 2015 Mar; 34(3):e63-70. Bartelink IH, Savic RM, Dorsey G, Ruel T, Gingrich D, Scherpbier HJ, Capparelli E, Jullien V, Young SL, Achan J, Plenty A, Charlebois E, Kamya M, Havlir D, Aweeka F. PMID: 25742090.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    134. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2015 Mar-Apr; 23(1):56-65. Havlir DV, Currier JS. PMID: 25965312.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    135. Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study. Clin Infect Dis. 2015 Jun 15; 60(12):1860-3. Luetkemeyer AF, Rosenkranz SL, Lu D, Grinsztejn B, Sanchez J, Ssemmanda M, Sanne I, McIlleron H, Havlir DV, Haas DW. PMID: 25722197.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    136. Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach. Trop Med Int Health. 2015 Apr; 20(4):537-45. Chamie G, Wandera B, Marquez C, Kato-Maeda M, Kamya MR, Havlir DV, Charlebois ED. PMID: 25583212.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    137. Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 2015 Jan 14; 29(2):183-91. Cohan D, Natureeba P, Koss CA, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Gandhi M, Clark TD, Nzarubara B, Achan J, Ruel T, Kamya MR, Havlir DV. PMID: 25426808.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    138. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial. AIDS. 2014 Nov 28; 28(18):2701-9. Kamya MR, Kapisi J, Bigira V, Clark TD, Kinara S, Mwangwa F, Muhindo MK, Kakuru A, Aweeka FT, Huang L, Jagannathan P, Achan J, Havlir DV, Rosenthal PJ, Dorsey G. PMID: 25493596.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    139. Household food insecurity, maternal nutritional status, and infant feeding practices among HIV-infected Ugandan women receiving combination antiretroviral therapy. Matern Child Health J. 2014 Nov; 18(9):2044-53. Young SL, Plenty AH, Luwedde FA, Natamba BK, Natureeba P, Achan J, Mwesigwa J, Ruel TD, Ades V, Osterbauer B, Clark TD, Dorsey G, Charlebois ED, Kamya M, Havlir DV, Cohan DL. PMID: 24585398.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    140. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy. . 2014 Oct 01; 67(2):128-35. Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D. PMID: 25072616.
      View in: PubMed   Mentions:
    141. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/µl in rural Uganda. AIDS. 2014 Sep 24; 28(15):2241-9. Jain V, Byonanebye DM, Amanyire G, Kwarisiima D, Black D, Kabami J, Chamie G, Clark TD, Rooney JF, Charlebois ED, Kamya MR, Havlir DV. PMID: 25022596.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    142. Assessing the quality of tuberculosis evaluation for children with prolonged cough presenting to routine community health care settings in rural Uganda. PLoS One. 2014; 9(8):e105935. Marquez C, Davis JL, Katamba A, Haguma P, Ochom E, Ayakaka I, Chamie G, Dorsey G, Kamya MR, Charlebois E, Havlir DV, Cattamanchi A. PMID: 25170875.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    143. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One. 2014; 9(8):e105690. Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, Dorsey G, Rosenthal PJ. PMID: 25144768.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    144. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr. 2014 Dec; 60(6):434-41. Marquez C, Okiring J, Chamie G, Ruel TD, Achan J, Kakuru A, Kamya MR, Charlebois ED, Havlir DV, Dorsey G. PMID: 25145704.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    145. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial. PLoS Med. 2014 Aug; 11(8):e1001689. Bigira V, Kapisi J, Clark TD, Kinara S, Mwangwa F, Muhindo MK, Osterbauer B, Aweeka FT, Huang L, Achan J, Havlir DV, Rosenthal PJ, Kamya MR, Dorsey G. PMID: 25093754.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    146. Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. J Infect Dis. 2014 Dec 15; 210(12):1938-45. Natureeba P, Ades V, Luwedde F, Mwesigwa J, Plenty A, Okong P, Charlebois ED, Clark TD, Nzarubara B, Havlir DV, Achan J, Kamya MR, Cohan D, Dorsey G. PMID: 24958908.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    147. CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2014 May; 22(2):602-15. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 24901886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    148. Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. Clin Infect Dis. 2014 Aug 01; 59(3):446-53. Kakuru A, Achan J, Muhindo MK, Ikilezi G, Arinaitwe E, Mwangwa F, Ruel T, Clark TD, Charlebois E, Rosenthal PJ, Havlir D, Kamya MR, Tappero JW, Dorsey G. PMID: 24759826.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    149. Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy. . 2014 Apr 15; 65(5):535-41. Ruel TD, Kakuru A, Ikilezi G, Mwangwa F, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Kamya M, Achan J. PMID: 24326597.
      View in: PubMed   Mentions:
    150. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs. . 2014 Apr 01; 65(4):423-8. Luetkemeyer AF, Kendall MA, Nyirenda M, Wu X, Ive P, Benson CA, Andersen JW, Swindells S, Sanne IM, Havlir DV, Kumwenda J. PMID: 24226057.
      View in: PubMed   Mentions:
    151. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014 Apr; 14(4):281-90. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS. PMID: 24602844.
      View in: PubMed   Mentions: 172     Fields:    Translation:HumansCellsCTClinical Trials
    152. Changes in population HIV RNA levels in Mbarara, Uganda, during scale-up of HIV antiretroviral therapy access. . 2014 Mar 01; 65(3):327-32. Jain V, Byonanebye DM, Liegler T, Kwarisiima D, Chamie G, Kabami J, Petersen ML, Balzer LB, Clark TD, Black D, Thirumurthy H, Geng EH, Charlebois ED, Amanyire G, Kamya MR, Havlir DV. PMID: 24146022.
      View in: PubMed   Mentions:
    153. Evaluating linkage to care for hypertension after community-based screening in rural Uganda. Trop Med Int Health. 2014 Apr; 19(4):459-68. Kotwani P, Balzer L, Kwarisiima D, Clark TD, Kabami J, Byonanebye D, Bainomujuni B, Black D, Chamie G, Jain V, Thirumurthy H, Kamya MR, Geng EH, Petersen ML, Havlir DV, Charlebois ED. PMID: 24495307.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    154. A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells. AIDS. 2014 Jan 28; 28(3):439-42. Yukl SA, Sinclair E, Somsouk M, Hunt PW, Epling L, Killian M, Girling V, Li P, Havlir DV, Deeks SG, Wong JK, Hatano H. PMID: 24322272.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    155. Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus. Am J Cardiol. 2014 Apr 01; 113(7):1260-5. Moyers BS, Secemsky EA, Vittinghoff E, Wong JK, Havlir DV, Hsue PY, Tseng ZH. PMID: 24521717.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    156. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol. 2014 Apr; 52(4):1052-9. Luetkemeyer AF, Kendall MA, Wu X, Lourenço MC, Jentsch U, Swindells S, Qasba SS, Sanchez J, Havlir DV, Grinsztejn B, Sanne IM, Firnhaber C. PMID: 24430455.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    157. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda. PLoS One. 2014; 9(1):e84317. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Balzer LB, Petersen ML, Thirumurthy H, Charlebois ED, Kamya MR, Havlir DV. PMID: 24392124.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    158. Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study. BMC Public Health. 2013 Dec 09; 13:1151. Kotwani P, Kwarisiima D, Clark TD, Kabami J, Geng EH, Jain V, Chamie G, Petersen ML, Thirumurthy H, Kamya MR, Charlebois ED, Havlir DV. PMID: 24321133.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    159. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013 Nov 02; 382(9903):1525-33. Deeks SG, Lewin SR, Havlir DV. PMID: 24152939.
      View in: PubMed   Mentions: 392     Fields:    Translation:Humans
    160. Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS. Clin Infect Dis. 2013 Dec; 57(12):1766-72. Vijayan T, Semitala FC, Matsiko N, Elyanu P, Namusobya J, Havlir DV, Kamya M, Geng EH. PMID: 24065326.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    161. Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV-infected pregnant and breastfeeding women in Tororo, Uganda. J Clin Pharmacol. 2014 Feb; 54(2):121-32. Bartelink IH, Savic RM, Mwesigwa J, Achan J, Clark T, Plenty A, Charlebois E, Kamya M, Young SL, Gandhi M, Havlir D, Cohan D, Aweeka F. PMID: 24038035.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    162. Hair and plasma data show that lopinavir, ritonavir, and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding. . 2013 Aug 15; 63(5):578-84. Gandhi M, Mwesigwa J, Aweeka F, Plenty A, Charlebois E, Ruel TD, Huang Y, Clark T, Ades V, Natureeba P, Luwedde FA, Achan J, Kamya MR, Havlir DV, Cohan D. PMID: 24135775.
      View in: PubMed   Mentions:
    163. Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, Uganda. AIDS Care. 2014; 26(3):360-6. Kim LH, Arinaitwe E, Nzarubara B, Kamya MR, Clark TD, Okong P, Charlebois ED, Havlir DV, Cohan D. PMID: 23909832.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    164. High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/µL under routine program conditions in Uganda. Clin Infect Dis. 2013 Nov; 57(9):1343-50. Namusobya J, Semitala FC, Amanyire G, Kabami J, Chamie G, Bogere J, Jain V, Clark TD, Charlebois E, Havlir DV, Kamya M, Geng EH. PMID: 23899683.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    165. Overcoming the human immunodeficiency virus obstacle course. JAMA Intern Med. 2013 Jul 22; 173(14):1344-5. Christopoulos KA, Havlir DV. PMID: 23778428.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    166. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J Infect Dis. 2013 Oct 15; 208(8):1212-20. Yukl SA, Shergill AK, Ho T, Killian M, Girling V, Epling L, Li P, Wong LK, Crouch P, Deeks SG, Havlir DV, McQuaid K, Sinclair E, Wong JK. PMID: 23852128.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    167. Neonatal mortality in HIV-exposed infants born to women receiving combination antiretroviral therapy in Rural Uganda. J Trop Pediatr. 2013 Dec; 59(6):441-6. Ades V, Mwesigwa J, Natureeba P, Clark TD, Plenty A, Charlebois E, Achan J, Kamya MR, Havlir DV, Cohan D, Ruel TD. PMID: 23764539.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    168. Household ventilation and tuberculosis transmission in Kampala, Uganda. Int J Tuberc Lung Dis. 2013 Jun; 17(6):764-70. Chamie G, Wandera B, Luetkemeyer A, Bogere J, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 23676159.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    169. Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria. AIDS. 2013 Apr 24; 27(7):1159-65. Nosyk B, Audoin B, Beyrer C, Cahn P, Granich R, Havlir D, Katabira E, Lange J, Lima VD, Patterson T, Strathdee SA, Williams B, Montaner J. PMID: 23902921.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    170. Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. Clin Infect Dis. 2013 Aug; 57(4):586-93. Luetkemeyer AF, Rosenkranz SL, Lu D, Marzan F, Ive P, Hogg E, Swindells S, Benson CA, Grinsztejn B, Sanne IM, Havlir DV, Aweeka F. PMID: 23592830.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    171. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy. Top Antivir Med. 2013 Apr-May; 21(2):62-74. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 23681961.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    172. WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity. . 2013 Mar 01; 62(3):e101-3. Cohan D, Mwesigwa J, Natureeba P, Aliba Luwedde F, Ades V, Plenty A, Kakuru A, Achan J, Clark T, Osterbauer B, Kamya M, Havlir D. PMID: 23924639.
      View in: PubMed   Mentions:
    173. Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda. AIDS. 2013 Feb 20; 27(4):627-34. Thirumurthy H, Chamie G, Jain V, Kabami J, Kwarisiima D, Clark TD, Geng E, Petersen ML, Charlebois ED, Kamya MR, Havlir DV. PMID: 23169332.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    174. Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. Am J Trop Med Hyg. 2013 Apr; 88(4):744-6. Ikilezi G, Achan J, Kakuru A, Ruel T, Charlebois E, Clark TD, Rosenthal PJ, Havlir D, Kamya MR, Dorsey G. PMID: 23358639.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    175. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. Clin Infect Dis. 2013 Feb; 56(4):598-605. Jain V, Liegler T, Kabami J, Chamie G, Clark TD, Black D, Geng EH, Kwarisiima D, Wong JK, Abdel-Mohsen M, Sonawane N, Aweeka FT, Thirumurthy H, Petersen ML, Charlebois ED, Kamya MR, Havlir DV. PMID: 23243180.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    176. Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. N Engl J Med. 2012 Nov 29; 367(22):2110-8. Achan J, Kakuru A, Ikilezi G, Ruel T, Clark TD, Nsanzabana C, Charlebois E, Aweeka F, Dorsey G, Rosenthal PJ, Havlir D, Kamya MR. PMID: 23190222.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansPHPublic Health
    177. PR Interval and sudden cardiac death in patients with HIV infection. J Infect Dis. 2013 Jan 01; 207(1):199-200. Tseng ZH, Moyers B, Secemsky EA, Havlir DV, Hsue PY. PMID: 23186784.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    178. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2012 Nov 13; 26(17):2121-33. Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. PMID: 22695302.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    179. Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers. . 2012 Nov 01; 61(3):310-6. Huang L, Parikh S, Rosenthal PJ, Lizak P, Marzan F, Dorsey G, Havlir D, Aweeka FT. PMID: 22918158.
      View in: PubMed   Mentions:
    180. The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/µL in a public health setting. Clin Infect Dis. 2012 Dec; 55(12):1690-7. Geng EH, Hare CB, Kahn JO, Jain V, Van Nunnery T, Christopoulos KA, Deeks SG, Gandhi M, Havlir DV. PMID: 22955429.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsPHPublic Health
    181. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One. 2012; 7(8):e43400. Chamie G, Kwarisiima D, Clark TD, Kabami J, Jain V, Geng E, Petersen ML, Thirumurthy H, Kamya MR, Havlir DV, Charlebois ED. PMID: 22916256.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    182. Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy. PLoS One. 2012; 7(8):e41934. Young S, Murray K, Mwesigwa J, Natureeba P, Osterbauer B, Achan J, Arinaitwe E, Clark T, Ades V, Plenty A, Charlebois E, Ruel T, Kamya M, Havlir D, Cohan D. PMID: 22879899.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    183. The beginning of the end of AIDS? N Engl J Med. 2012 Aug 23; 367(8):685-7. Havlir D, Beyrer C. PMID: 22809362.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    184. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2012 Jun-Jul; 20(2):48-60. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 22710907.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    185. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012 May 22; 59(21):1891-6. Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, Havlir DV, Hsue PY. PMID: 22595409.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    186. Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clin Infect Dis. 2012 May; 54 Suppl 4:S245-9. Jordan MR, Bennett DE, Wainberg MA, Havlir D, Hammer S, Yang C, Morris L, Peeters M, Wensing AM, Parkin N, Nachega JB, Phillips A, De Luca A, Geng E, Calmy A, Raizes E, Sandstrom P, Archibald CP, Perriëns J, McClure CM, Hong SY, McMahon JH, Dedes N, Sutherland D, Bertagnolio S. PMID: 22544182.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    187. Social, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected men. PLoS One. 2012; 7(4):e35207. Riley ED, Neilands TB, Moore K, Cohen J, Bangsberg DR, Havlir D. PMID: 22558128.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    188. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis. 2012 Apr; 54(7):1001-9. Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, Rosenthal PJ, Dorsey G, Achan J, Akello C, Kamya MR, Wong JK. PMID: 22308272.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    189. HIV and tuberculosis--science and implementation to turn the tide and reduce deaths. J Int AIDS Soc. 2012; 15(2):17396. Harries AD, Lawn SD, Getahun H, Zachariah R, Havlir DV. PMID: 22905358.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    190. The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa. Future Virol. 2012; 7(7):699-708. Kamya MR, Byakika-Kibwika P, Gasasira AF, Havlir D, Rosenthal PJ, Dorsey G, Achan J. PMID: 23293660.
      View in: PubMed   Mentions:
    191. Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection. AIDS. 2011 Nov 28; 25(18):2269-78. Haubrich RH, Riddler SA, Ribaudo H, Direnzo G, Klingman KL, Garren KW, Butcher DL, Rooney JF, Havlir DV, Mellors JW. PMID: 21941167.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    192. Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia. . 2011 Nov 01; 58(3):e96-9. Luetkemeyer AF, Charlebois ED, Hare CB, Black D, Smith A, Havlir DV, Peters MG. PMID: 22005002.
      View in: PubMed   Mentions:
    193. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011 Oct 20; 365(16):1482-91. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, Hogg E, Rooney JF, Wu X, Hosseinipour MC, Lalloo U, Veloso VG, Some FF, Kumarasamy N, Padayatchi N, Santos BR, Reid S, Hakim J, Mohapi L, Mugyenyi P, Sanchez J, Lama JR, Pape JW, Sanchez A, Asmelash A, Moko E, Sawe F, Andersen J, Sanne I. PMID: 22010914.
      View in: PubMed   Mentions: 224     Fields:    Translation:HumansCells
    194. The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation. Clin Infect Dis. 2011 Nov; 53(10):1008-14. Geng EH, Kahn JS, Chang OC, Hare CB, Christopoulos KA, Jones D, Petersen ML, Deeks SG, Havlir DV, Gandhi M. PMID: 21960715.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    195. Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda. J Trop Pediatr. 2012 Jun; 58(3):194-9. Kay J, Wanzira H, Sandison T, Kakuru A, Bigira V, Kamya M, Homsy J, Tappero JW, Havlir D, Dorsey G, Ruel T. PMID: 21930666.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    196. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4? T-cell counts of = 350 cells/µL. J Infect Dis. 2011 Sep 15; 204(6):884-92. Nanteza MW, Mayanja-Kizza H, Charlebois E, Srikantiah P, Lin R, Mupere E, Mugyenyi P, Boom WH, Mugerwa RD, Havlir DV, Whalen CC. PMID: 21849285.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    197. Tuberculosis drug development: ensuring people living with HIV are not left behind. Am J Respir Crit Care Med. 2011 Nov 15; 184(10):1107-13. Luetkemeyer AF, Getahun H, Chamie G, Lienhardt C, Havlir DV. PMID: 21868507.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    198. Sex differences in HIV RNA level and CD4 cell percentage during childhood. Clin Infect Dis. 2011 Sep; 53(6):592-9. Ruel TD, Zanoni BC, Ssewanyana I, Cao H, Havlir DV, Kamya M, Achan J, Charlebois ED, Feeney ME. PMID: 21840929.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    199. Mortality among antiretroviral-eligible patients in an urban public clinic. . 2011 Aug 01; 57(4):297-300. Dowdy DW, Geng EH, Christopoulos KA, Kahn JS, Hare CB, Wlodarczyk D, Havlir DV. PMID: 21602697.
      View in: PubMed   Mentions:
    200. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011 Aug 11; 365(6):493-505. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR. PMID: 21767103.
      View in: PubMed   Mentions: 2672     Fields:    Translation:HumansCells
    201. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2011 May-Jun; 19(2):58-68. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 21868823.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    202. Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. J Virol Methods. 2011 Aug; 175(2):261-5. Yukl SA, Li P, Fujimoto K, Lampiris H, Lu CM, Hare CB, Deeks SG, Liegler T, Pandori M, Havlir DV, Wong JK. PMID: 21536073.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    203. The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis. 2011 Apr 15; 52(8):1046-9. Charlebois ED, Das M, Porco TC, Havlir DV. PMID: 21460322.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    204. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. J Infect Dis. 2011 Apr 01; 203(7):992-1001. Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, Nalukwago S, Charlebois E, Havlir D, Mayanja-Kizza H, Whalen CC, Boom WH. PMID: 21402550.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    205. Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. . 2011 Jan 01; 56(1):44-50. Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, Liegler T, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK, Achan J. PMID: 21099693.
      View in: PubMed   Mentions:
    206. Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy. . 2010 Nov; 55(3):330-5. Charlebois ED, Ruel TD, Gasasira AF, Achan J, Kateera F, Akello C, Cao H, Dorsey G, Rosenthal PJ, Ssewanyana I, Kamya MR, Havlir DV. PMID: 20592617.
      View in: PubMed   Mentions:
    207. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2010 Oct 23; 24(16):2451-60. Yukl SA, Shergill AK, McQuaid K, Gianella S, Lampiris H, Hare CB, Pandori M, Sinclair E, Günthard HF, Fischer M, Wong JK, Havlir DV. PMID: 20827162.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCells
    208. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis. 2010 Nov 15; 202(10):1553-61. Yukl SA, Gianella S, Sinclair E, Epling L, Li Q, Duan L, Choi AL, Girling V, Ho T, Li P, Fujimoto K, Lampiris H, Hare CB, Pandori M, Haase AT, Günthard HF, Fischer M, Shergill AK, McQuaid K, Havlir DV, Wong JK. PMID: 20939732.
      View in: PubMed   Mentions: 138     Fields:    Translation:HumansCellsCTClinical Trials
    209. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. Int J Tuberc Lung Dis. 2010 Oct; 14(10):1295-302. Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. PMID: 20843421.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    210. Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes. J Virol Methods. 2010 Dec; 170(1-2):115-20. Li P, Ruel T, Fujimoto K, Hatano H, Yukl S, Eller LA, Liegler T, Kamya M, Gassasira A, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK. PMID: 20863855.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    211. AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. J Infect Dis. 2010 Sep 01; 202(5):705-16. Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, Pollard R, Battaglia C, Robertson M, Mehrotra D, Casimiro D, Cox K, Schock B. PMID: 20662716.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCellsPHPublic Health
    212. "A bird in the hand...": a commentary on the test and treat approach for HIV. Arch Intern Med. 2010 Aug 09; 170(15):1354-6. Charlebois ED, Havlir DV. PMID: 20696961.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    213. Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count. Clin Infect Dis. 2010 Aug 01; 51(3):359-62. Chamie G, Charlebois ED, Srikantiah P, Walusimbi-Nanteza M, Mugerwa RD, Mayanja H, Okwera A, Whalen CC, Havlir DV. PMID: 20569064.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    214. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS. 2010 Jul 31; 24(12):1945-52. Bebell LM, Pilcher CD, Dorsey G, Havlir D, Kamya MR, Busch MP, Dunn Williams J, Nugent CT, Bentsen C, Rosenthal PJ, Charlebois ED. PMID: 20543656.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    215. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar J. 2010 Jun 23; 9:177. Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, Ruel T, Kateera F, Meya DN, Havlir D, Rosenthal PJ, Dorsey G. PMID: 20573194.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    216. Tuberculosis as part of the natural history of HIV infection in developing countries. Clin Infect Dis. 2010 May 15; 50 Suppl 3:S245-54. Chamie G, Luetkemeyer A, Charlebois E, Havlir DV. PMID: 20397955.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    217. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS. 2010 May 15; 24(8):1163-70. Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, Eller LA, Charlebois E, Havlir DV, Kamya MR, Achan J, Akello C, Wong JK. PMID: 20425886.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    218. Complications of HIV disease and antiretroviral treatment. Top HIV Med. 2010 Apr-May; 18(2):57-65. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 20516525.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    219. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010 Apr 20; 74(16):1260-6. Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ. PMID: 20237308.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCTClinical Trials
    220. Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. PLoS One. 2010 Feb 22; 5(2):e9138. Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, Chervenak KA, Mugerwa RD, Havlir DV, Mayanja-Kizza H, Whalen CC, Boom WH. PMID: 20179751.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    221. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J. 2009 Nov 14; 8:254. Newman PM, Wanzira H, Tumwine G, Arinaitwe E, Waldman S, Achan J, Havlir D, Rosenthal PJ, Dorsey G, Clark TD, Cohan D. PMID: 19912657.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    222. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. . 2009 Aug 01; 51(4):424-9. German P, Parikh S, Lawrence J, Dorsey G, Rosenthal PJ, Havlir D, Charlebois E, Hanpithakpong W, Lindegardh N, Aweeka FT. PMID: 19506482.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    223. Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS. 2009 Jun 01; 23(9):1109-18. Haubrich RH, Riddler SA, DiRienzo AG, Komarow L, Powderly WG, Klingman K, Garren KW, Butcher DL, Rooney JF, Haas DW, Mellors JW, Havlir DV. PMID: 19417580.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCellsCTClinical Trials
    224. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2009 Apr-May; 17(2):57-67. Currier JS, Havlir DV. PMID: 19401608.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    225. Paradigm shift to address drug resistant tuberculosis in people living with HIV needed, and needed now. Trop Med Int Health. 2009 Apr; 14(4):376-8. Getahun H, Havlir D, Granich R, Reid A, Jaramillo E, Nunn P. PMID: 19302631.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    226. Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Clin Immunol. 2009 Jun; 131(3):410-4. Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya MR, Kekitiinwa A, Wong JK, Cao H, Havlir D, Charlebois ED. PMID: 19303366.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    227. Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis. 2009 Mar 15; 48(6):725-32. Davis JL, Huang L, Kovacs JA, Masur H, Murray P, Havlir DV, Worodria WO, Charlebois ED, Srikantiah P, Cattamanchi A, Huber C, Shea YR, Chow Y, Fischer SH. PMID: 19207077.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    228. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 2009 Apr 25; 387(1):98-108. Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. PMID: 19268337.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    229. The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda. AIDS Res Hum Retroviruses. 2009 Jan; 25(1):65-71. Ssewanyana I, Baker CA, Ruel T, Bousheri S, Kamya M, Dorsey G, Rosenthal PJ, Charlebois E, Havlir D, Cao H. PMID: 19182922.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    230. Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. . 2008 Dec 01; 49(4):458-60. Srikantiah P, Wong JK, Liegler T, Walusimbi M, Mayanja-Kizza H, Kayanja HK, Mugerwa RD, Charlebois ED, Boom WH, Whalen CC, Havlir DV. PMID: 19011423.
      View in: PubMed   Mentions:
    231. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings. Int J Tuberc Lung Dis. 2008 Dec; 12(12):1370-5. Scano F, Vitoria M, Burman W, Harries AD, Gilks CF, Havlir D. PMID: 19017444.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    232. Confronting TB/HIV in the era of increasing anti-TB drug resistance. J Int AIDS Soc. 2008 Nov 06; 11:6. Chakaya J, Getahun H, Granich R, Havlir D. PMID: 19014421.
      View in: PubMed   Mentions: 3     Fields:    
    233. Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis. 2008 Aug 01; 47(3):421-4. Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV. PMID: 18558886.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    234. HIV integrase inhibitors--out of the pipeline and into the clinic. N Engl J Med. 2008 Jul 24; 359(4):416-8. Havlir DV. PMID: 18650518.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    235. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008 Jul 23; 300(4):423-30. Havlir DV, Getahun H, Sanne I, Nunn P. PMID: 18647985.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansPHPublic Health
    236. HIV RNA suppression among HIV-infected Ugandan children with measles. . 2008 Jun 01; 48(2):225-7. Ruel TD, Achan J, Gasasira AF, Charlebois ED, Mehbratu T, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir DV. PMID: 18520684.
      View in: PubMed   Mentions:
    237. Class-sparing regimens for initial treatment of HIV-1 infection. N Engl J Med. 2008 May 15; 358(20):2095-106. Riddler SA, Haubrich R, DiRienzo AG, Peeples L, Powderly WG, Klingman KL, Garren KW, George T, Rooney JF, Brizz B, Lalloo UG, Murphy RL, Swindells S, Havlir D, Mellors JW. PMID: 18480202.
      View in: PubMed   Mentions: 224     Fields:    Translation:HumansCellsCTClinical Trials
    238. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy. Top HIV Med. 2008 Apr-May; 16(1):23-30. Currier JS, Havlir DV. PMID: 18441380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    239. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clin Infect Dis. 2008 Apr 01; 46(7):985-91. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G. PMID: 18444813.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    240. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008 Feb 01; 197(3):411-9. Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK. PMID: 18248304.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    241. HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda. . 2007 Dec 15; 46(5):624-30. Bebell LM, Gasasira A, Kiggundu M, Dokomajilar C, Kamya MR, Charlebois ED, Havlir D, Rosenthal PJ, Dorsey G. PMID: 18043317.
      View in: PubMed   Mentions:
    242. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007 Dec 15; 45(12):1633-9. Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM. PMID: 18190326.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    243. Profile of T cell immune responses in HIV-infected children from Uganda. J Infect Dis. 2007 Dec 01; 196(11):1667-70. Ssewanyana I, Elrefaei M, Dorsey G, Ruel T, Jones NG, Gasasira A, Kamya M, Nakiwala J, Achan J, Charlebois E, Havlir D, Cao H. PMID: 18008251.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    244. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS. 2007 Oct 01; 21(15):2059-66. Kamya MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G. PMID: 17885296.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    245. Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda. AIDS. 2007 Sep 12; 21(14):1972-4. Srikantiah P, Walusimbi MN, Kayanja HK, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois ED, Boom WH, Whalen CC, Havlir DV. PMID: 17721107.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    246. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. J Infect Dis. 2007 Aug 15; 196 Suppl 1:S46-51. Blanc FX, Havlir DV, Onyebujoh PC, Thim S, Goldfeld AE, Delfraissy JF. PMID: 17624825.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    247. High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response. HIV Clin Trials. 2007 Jul-Aug; 8(4):193-204. Podzamczer D, King MS, Klein CE, Flexner C, Katlama C, Havlir DV, Letendre SL, Eron JJ, Brun SC, Bernstein B. PMID: 17720659.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    248. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. J Infect Dis. 2007 May 15; 195(10):1426-36. Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM. PMID: 17436222.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    249. Complications of HIV disease and therapy. Top HIV Med. 2007 Apr-May; 15(2):40-7. Currier JS, Havlir DV. PMID: 17485786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    250. Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. Clin Infect Dis. 2007 Mar 15; 44(6):889-91. German P, Greenhouse B, Coates C, Dorsey G, Rosenthal PJ, Charlebois E, Lindegardh N, Havlir D, Aweeka FT. PMID: 17304470.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    251. Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. Int J Tuberc Lung Dis. 2007 Feb; 11(2):168-74. Srikantiah P, Lin R, Walusimbi M, Okwera A, Luzze H, Whalen CC, Boom WH, Havlir DV, Charlebois ED. PMID: 17263287.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    252. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007 Apr 01; 175(7):737-42. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. PMID: 17218620.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    253. A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. J Infect Dis. 2006 Nov 01; 194(9):1309-18. Benson CA, Vaida F, Havlir DV, Downey GF, Lederman MM, Gulick RM, Glesby MJ, Wantman M, Bixby CJ, Rinehart AR, Snyder S, Wang R, Patel S, Mellors JW. PMID: 17041858.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    254. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol. 2006 Aug; 44(8):3021-4. Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois ED. PMID: 16891532.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    255. Intensive care of patients with HIV infection. N Engl J Med. 2006 Jul 13; 355(2):173-81. Huang L, Quartin A, Jones D, Havlir DV. PMID: 16837681.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    256. Antiretroviral therapy and TB. Trop Doct. 2006 Apr; 36(2):73-9. Swaminathan S, Luetkemeyer A, Srikantiah P, Lin R, Charlebois E, Havlir DV. PMID: 16611437.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    257. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2006 Mar-Apr; 14(1):27-35. Havlir DV, Currier JS. PMID: 16641525.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    258. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. . 2006 Jan 01; 41(1):31-6. Luetkemeyer A, Hare CB, Stansell J, Tien PC, Charlesbois E, Lum P, Havlir D, Peters M. PMID: 16340470.
      View in: PubMed   Mentions:
    259. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis. 2006 Jan 01; 193(1):9-15. Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D. PMID: 16323126.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    260. Patents versus patients? Antiretroviral therapy in India. N Engl J Med. 2005 Aug 25; 353(8):749-51. Havlir DV, Hammer SM. PMID: 16120852.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    261. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother. 2005 Jul; 49(7):2983-5. Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. PMID: 15980379.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimals
    262. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 01; 191(9):1410-8. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. PMID: 15809898.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    263. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2005 Mar-Apr; 13(1):16-23. Currier JS, Havlir DV. PMID: 15849369.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    264. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. J Infect Dis. 2005 Apr 01; 191(7):1164-8. Havlir DV, Koelsch KK, Strain MC, Margot N, Lu B, Ignacio CC, Miller MD, Wong JK. PMID: 15747253.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    265. Rapid increase in tuberculosis incidence soon after infection with HIV--a new twist in the twin epidemics. J Infect Dis. 2005 Jan 15; 191(2):147-9. Srikantiah P, Charlebois E, Havlir DV. PMID: 15609222.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    266. The case for earlier treatment of HIV infection. Clin Infect Dis. 2004 Dec 01; 39(11):1699-704. Holmberg SD, Palella FJ, Lichtenstein KA, Havlir DV. PMID: 15578373.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    267. Atazanavir: new option for treatment of HIV infection. Clin Infect Dis. 2004 Jun 01; 38(11):1599-604. Havlir DV, O'Marro SD. PMID: 15156449.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    268. Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA. Top HIV Med. 2004 Mar-Apr; 12(1):31-45. Currier JS, Havlir DV. PMID: 15111728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    269. Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. AIDS. 2003 Nov 07; 17(16):2345-9. Gulick RM, Meibohm A, Havlir D, Eron JJ, Mosley A, Chodakewitz JA, Isaacs R, Gonzalez C, McMahon D, Richman DD, Robertson M, Mellors JW. PMID: 14571186.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    270. Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J Virol. 2003 Oct; 77(20):11212-9. Havlir DV, Strain MC, Clerici M, Ignacio C, Trabattoni D, Ferrante P, Wong JK. PMID: 14512569.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCellsCTClinical Trials
    271. Strategic approaches to antiretroviral treatment. Top HIV Med. 2003 Jul-Aug; 11(4):145-9. Havlir DV. PMID: 12876333.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    272. Responding to organ failure in HIV-infected patients. N Engl J Med. 2003 Jun 05; 348(23):2279-81. Roland ME, Havlir DV. PMID: 12788990.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    273. Complications of HIV infection and antiretroviral therapy. Top HIV Med. 2003 May-Jun; 11(3):86-91. Havlir DV, Currier JS. PMID: 12837967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    274. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8):4819-24. Strain MC, Günthard HF, Havlir DV, Ignacio CC, Smith DM, Leigh-Brown AJ, Macaranas TR, Lam RY, Daly OA, Fischer M, Opravil M, Levine H, Bacheler L, Spina CA, Richman DD, Wong JK. PMID: 12684537.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansCells
    275. Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia. Antimicrob Agents Chemother. 2002 Dec; 46(12):3907-16. Shulman N, Zolopa A, Havlir D, Hsu A, Renz C, Boller S, Jiang P, Rode R, Gallant J, Race E, Kempf DJ, Sun E. PMID: 12435695.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    276. Coadministration of indinavir and nelfinavir in human immunodeficiency virus type 1-infected adults: safety, pharmacokinetics, and antiretroviral activity. Antimicrob Agents Chemother. 2002 Dec; 46(12):3877-82. Riddler SA, Havlir D, Squires KE, Kerr B, Lewis RH, Yeh K, Wynne LH, Zhong L, Peng Y, Deutsch P, Saah A. PMID: 12435691.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    277. Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med. 2002 Sep; 23(3):665-74. Jones D, Havlir DV. PMID: 12371002.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    278. Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. . 2002 Sep 01; 31(1):20-6. Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD. PMID: 12352146.
      View in: PubMed   Mentions:
    279. The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society. AIDS. 2002 Jul 05; 16(10):7-9. Havlir D, Vella S, Hammer S. PMID: 12146462.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    280. A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298). AIDS Res Hum Retroviruses. 2002 Jul 01; 18(10):699-704. Pollard RB, Tierney C, Havlir D, Tebas P, Fox L, Smeaton L, Richman D, Friedland GH. PMID: 12167276.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    281. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002 Apr; 8(4):379-85. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. PMID: 11927944.
      View in: PubMed   Mentions: 483     Fields:    Translation:HumansCells
    282. To stop or not to stop: that is the question, but what is the answer? AIDS. 2002 Mar 29; 16(5):787-9. Hogg RS, Havlir D, Miller V, Montaner JS. PMID: 11964536.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    283. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS. 2002 Jan 25; 16(2):161-70. Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman DD, Rowland-Jones SL, Spina CA. PMID: 11807299.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    284. Structured intermittent treatment for HIV disease: Necessary concession or premature compromise? Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):4-6. Havlir DV. PMID: 11782542.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    285. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. J Virol. 2002 Jan; 76(1):185-94. Casimiro DR, Tang A, Perry HC, Long RS, Chen M, Heidecker GJ, Davies ME, Freed DC, Persaud NV, Dubey S, Smith JG, Havlir D, Richman D, Chastain MA, Simon AJ, Fu TM, Emini EA, Shiver JW. PMID: 11739684.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    286. Adding two new drug classes improves outcome in salvage therapy. AIDS Clin Care. 2001 Oct; 13(10):99. Havlir D. PMID: 11590928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    287. Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS. 2001 Jul 27; 15(11):1379-88. Havlir DV, Gilbert PB, Bennett K, Collier AC, Hirsch MS, Tebas P, Adams EM, Wheat LJ, Goodwin D, Schnittman S, Holohan MK, Richman DD. PMID: 11504959.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    288. Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA. 2001 Jul 11; 286(2):171-9. Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK. PMID: 11448280.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCells
    289. Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy. Virology. 2001 Jun 05; 284(2):250-8. Frost SD, Günthard HF, Wong JK, Havlir D, Richman DD, Leigh Brown AJ. PMID: 11384224.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    290. Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy. J Infect Dis. 2001 May 15; 183(10):1455-65. Huang W, De Gruttola V, Fischl M, Hammer S, Richman D, Havlir D, Gulick R, Squires K, Mellors J. PMID: 11319681.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    291. Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. J Infect Dis. 2001 May 01; 183(9):1318-27. Günthard HF, Havlir DV, Fiscus S, Zhang ZQ, Eron J, Mellors J, Gulick R, Frost SD, Brown AJ, Schleif W, Valentine F, Jonas L, Meibohm A, Ignacio CC, Isaacs R, Gamagami R, Emini E, Haase A, Richman DD, Wong JK. PMID: 11294662.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    292. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis. 2001 Feb 15; 183(4):555-62. Schacker T, Little S, Connick E, Gebhard K, Zhang ZQ, Krieger J, Pryor J, Havlir D, Wong JK, Schooley RT, Richman D, Corey L, Haase AT. PMID: 11170980.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    293. Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. J Clin Microbiol. 2001 Jan; 39(1):298-303. Havlir DV, Torriani FJ, Schrier RD, Huang JY, Lederman MM, Chervenak KA, Boom WH. PMID: 11136787.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    294. Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients. AIDS. 2000 Dec 22; 14(18):2869-76. Zhou XJ, Havlir DV, Richman DD, Acosta EP, Hirsch M, Collier AC, Tebas P, Sommadossi JP. PMID: 11153668.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    295. Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects. J Infect Dis. 2000 Dec; 182(6):1658-63. Havlir DV, Schrier RD, Torriani FJ, Chervenak K, Hwang JY, Boom WH. PMID: 11069237.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    296. Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication. AIDS. 2000 Jul 28; 14(11):1481-8. Ioannidis JP, Havlir DV, Tebas P, Hirsch MS, Collier AC, Richman DD. PMID: 10983634.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    297. In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis. 2000 Jul; 182(1):321-5. Havlir DV, Tierney C, Friedland GH, Pollard RB, Smeaton L, Sommadossi JP, Fox L, Kessler H, Fife KH, Richman DD. PMID: 10882616.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCellsCTClinical Trials
    298. 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine. Ann Intern Med. 2000 Jul 04; 133(1):35-9. Gulick RM, Mellors JW, Havlir D, Eron JJ, Meibohm A, Condra JH, Valentine FT, McMahon D, Gonzalez C, Jonas L, Emini EA, Chodakewitz JA, Isaacs R, Richman DD. PMID: 10877738.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsCTClinical Trials
    299. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000 Jul 03; 192(1):63-75. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, Havlir DV, Richman DD, Waters A, Easterbrook P, McMichael AJ, Rowland-Jones SL. PMID: 10880527.
      View in: PubMed   Mentions: 236     Fields:    Translation:HumansCells
    300. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy. AIDS. 2000 May 05; 14(7):821-6. O'Brien TR, McDermott DH, Ioannidis JP, Carrington M, Murphy PM, Havlir DV, Richman DD. PMID: 10839590.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    301. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis. 2000 Feb; 181(2):522-31. Günthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD. PMID: 10669335.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsPHPublic Health
    302. Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. JAMA. 2000 Jan 12; 283(2):229-34. Havlir DV, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi JP, Richman DD. PMID: 10634339.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    303. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis. 2000 Jan; 181(1):354-7. Schacker T, Little S, Connick E, Gebhard-Mitchell K, Zhang ZQ, Krieger J, Pryor J, Havlir D, Wong JK, Richman D, Corey L, Haase AT. PMID: 10608788.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    304. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science. 1999 Nov 12; 286(5443):1353-7. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, Reinhart TA, Rogan M, Cavert W, Miller CJ, Veazey RS, Notermans D, Little S, Danner SA, Richman DD, Havlir D, Wong J, Jordan HL, Schacker TW, Racz P, Tenner-Racz K, Letvin NL, Wolinsky S, Haase AT. PMID: 10558989.
      View in: PubMed   Mentions: 349     Fields:    Translation:AnimalsCells
    305. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol. 1999 Nov; 73(11):9404-12. Günthard HF, Frost SD, Leigh-Brown AJ, Ignacio CC, Kee K, Perelson AS, Spina CA, Havlir DV, Hezareh M, Looney DJ, Richman DD, Wong JK. PMID: 10516049.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    306. Viral dynamics of acute HIV-1 infection. J Exp Med. 1999 Sep 20; 190(6):841-50. Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV. PMID: 10499922.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    307. Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment Group. Lancet. 1999 Sep 11; 354(9182):891-5. Dunne MW, Bozzette S, McCutchan JA, Dubé MP, Sattler FR, Forthal D, Kemper CA, Havlir D. PMID: 10489947.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    308. Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma. AIDS Res Hum Retroviruses. 1999 Sep 01; 15(13):1191-200. Vázquez-Rosales G, García Lerma JG, Yamamoto S, Switzer WM, Havlir D, Folks TM, Richman DD, Heneine W. PMID: 10480632.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    309. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A. 1999 Apr 27; 96(9):5169-72. Zhang ZQ, Schuler T, Cavert W, Notermans DW, Gebhard K, Henry K, Havlir DV, Günthard HF, Wong JK, Little S, Feinberg MB, Polis MA, Schrager LK, Schacker TW, Richman DD, Corey L, Danner SA, Haase AT. PMID: 10220437.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    310. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1999 Feb 04; 340(5):367-73. Havlir DV, Barnes PF. PMID: 9929528.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    311. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. Clin Infect Dis. 1999 Jan; 28(1):136-8. Dubé MP, Torriani FJ, See D, Havlir DV, Kemper CA, Leedom JM, Tilles JG, McCutchan JA, Sattler FR. PMID: 10028084.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    312. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clin Infect Dis. 1998 Dec; 27(6):1369-75. Havlir DV, Dubé MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Kumar PN, White AC, Witt MD, Nightingale SD, Sepkowitz KA, MacGregor RR, Cheeseman SH, Torriani FJ, Zelasky MT, Sattler FR, Bozzette SA. PMID: 9868644.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    313. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. N Engl J Med. 1998 10 29; 339(18):1261-8. Havlir DV, Marschner IC, Hirsch MS, Collier AC, Tebas P, Bassett RL, Ioannidis JP, Holohan MK, Leavitt R, Boone G, Richman DD. PMID: 9791141.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCellsCTClinical Trials
    314. Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus. Blood. 1998 Aug 15; 92(4):1317-23. Bessudo A, Rassenti L, Havlir D, Richman D, Feigal E, Kipps TJ. PMID: 9694720.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    315. Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. AIDS Res Hum Retroviruses. 1998 Jul 01; 14(10):869-76. Günthard HF, Wong JK, Ignacio CC, Havlir DV, Richman DD. PMID: 9671215.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    316. Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. JAMA. 1998 Jul 01; 280(1):35-41. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Jonas L, Meibohm A, Holder D, Schleif WA, Condra JH, Emini EA, Isaacs R, Chodakewitz JA, Richman DD. PMID: 9660361.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsCTClinical Trials
    317. Human immunodeficiency virus replication in AIDS patients with Mycobacterium avium complex bacteremia: a case control study. California Collaborative Treatment Group. J Infect Dis. 1998 Mar; 177(3):595-9. Havlir DV, Haubrich R, Hwang J, Dunne MW, Currier J, Forthal D, Torriani F, Richman DD, McCutchan JA. PMID: 9498437.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    318. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J Virol. 1998 Mar; 72(3):2422-8. Günthard HF, Wong JK, Ignacio CC, Guatelli JC, Riggs NL, Havlir DV, Richman DD. PMID: 9499103.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCellsCTClinical Trials
    319. New antiretrovirals and new combinations. AIDS. 1998; 12 Suppl A:S165-74. Havlir DV, Lange JM. PMID: 9632999.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    320. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997 Nov 14; 278(5341):1291-5. Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD. PMID: 9360926.
      View in: PubMed   Mentions: 717     Fields:    Translation:HumansCells
    321. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A. 1997 Nov 11; 94(23):12574-9. Wong JK, Günthard HF, Havlir DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E, Richman DD. PMID: 9356491.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsCTClinical Trials
    322. A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group. J Infect Dis. 1997 Nov; 176(5):1225-32. Dubé MP, Sattler FR, Torriani FJ, See D, Havlir DV, Kemper CA, Dezfuli MG, Bozzette SA, Bartok AE, Leedom JM, Tilles JG, McCutchan JA. PMID: 9359722.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    323. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997 Sep 11; 337(11):734-9. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA. PMID: 9287228.
      View in: PubMed   Mentions: 370     Fields:    Translation:HumansCTClinical Trials
    324. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol. 1997 Mar; 71(3):2059-71. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. PMID: 9032338.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    325. The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy. Springer Semin Immunopathol. 1997; 18(3):267-83. Havlir DV, Richman DD. PMID: 9089949.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    326. Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients. J Virol. 1996 Nov; 70(11):7894-9. Havlir DV, Eastman S, Gamst A, Richman DD. PMID: 8892912.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    327. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. N Engl J Med. 1996 Aug 08; 335(6):392-8. Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC, Witt MD, Bozzette SA, McCutchan JA. PMID: 8676932.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCellsCTClinical Trials
    328. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med. 1996 Jun 06; 334(23):1491-7. Spector SA, McKinley GF, Lalezari JP, Samo T, Andruczk R, Follansbee S, Sparti PD, Havlir DV, Simpson G, Buhles W, Wong R, Stempien M. PMID: 8618603.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    329. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Ann Intern Med. 1996 Jun 01; 124(11):984-94. Havlir DV, Richman DD. PMID: 8624066.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    330. Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. J Infect Dis. 1996 Apr; 173(4):942-9. Torriani FJ, Behling CA, McCutchan JA, Haubrich RH, Havlir DV. PMID: 8603975.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    331. Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo. J Virol. 1996 Jan; 70(1):628-34. Zhang H, Dornadula G, Wu Y, Havlir D, Richman DD, Pomerantz RJ. PMID: 8523584.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    332. Newer nucleosides: lamivudine and stavudine. AIDS. 1996; 10 Suppl A:S135-43. Katlama C, Havlir DV. PMID: 8883621.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    333. A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208. J Infect Dis. 1995 Nov; 172(5):1379-83. Havlir D, McLaughlin MM, Richman DD. PMID: 7594683.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    334. High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis. 1995 Mar; 171(3):537-45. Havlir D, Cheeseman SH, McLaughlin M, Murphy R, Erice A, Spector SA, Greenough TC, Sullivan JL, Hall D, Myers M. PMID: 7533197.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    335. Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Feb 01; 8(2):141-51. Cheeseman SH, Havlir D, McLaughlin MM, Greenough TC, Sullivan JL, Hall D, Hattox SE, Spector SA, Stein DS, Myers M. PMID: 7530585.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    336. Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop. Drugs. 1995; 49 Suppl 1:9-16; discussion 38-40. Richman DD, Havlir D. PMID: 7614902.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    337. Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia. J Infect Dis. 1994 Dec; 170(6):1601-5. Torriani FJ, McCutchan JA, Bozzette SA, Grafe MR, Havlir DV. PMID: 7996004.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    338. Mycobacterium avium complex: advances in therapy. Eur J Clin Microbiol Infect Dis. 1994 Nov; 13(11):915-24. Havlir DV. PMID: 7698117.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    339. Uveitis associated with rifabutin prophylaxis. Ann Intern Med. 1994 Oct 01; 121(7):510-2. Havlir D, Torriani F, Dubé M. PMID: 8067648.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    340. Transient bacteremia due to Mycobacterium avium complex in patients with AIDS. J Infect Dis. 1994 Aug; 170(2):488-93. Kemper CA, Havlir D, Bartok AE, Kane C, Camp B, Lane N, Deresinski SC. PMID: 8035044.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    341. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis. 1994 Jul; 170(1):157-64. Kemper CA, Havlir D, Haghighat D, Dubé M, Bartok AE, Sison JP, Yao Y, Yangco B, Leedom JM, Tilles JG. PMID: 8014492.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    342. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J Virol. 1994 Mar; 68(3):1660-6. Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D. PMID: 7509000.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansCells
    343. Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremia. J Clin Microbiol. 1993 Jul; 31(7):1794-8. Havlir D, Kemper CA, Deresinski SC. PMID: 8349755.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    344. Cryptosporidium infection and CD4 counts. Ann Intern Med. 1992 May 15; 116(10):840-2. Flanigan T, Whalen C, Turner J, Soave R, Toerner J, Havlir D, Kotler D. PMID: 1348918.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    345. A 19-year follow-up of tuberculin reactors. Assessment of skin test reactivity and in vitro lymphocyte responses. Chest. 1991 May; 99(5):1172-6. Havlir DV, van der Kuyp F, Duffy E, Marshall R, Hom D, Ellner JJ. PMID: 2019174.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    346. Human immune response to Mycobacterium tuberculosis antigens. Infect Immun. 1991 Feb; 59(2):665-70. Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, Ellner JJ. PMID: 1898911.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    347. Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J Clin Invest. 1991 Feb; 87(2):729-33. Havlir DV, Ellner JJ, Chervenak KA, Boom WH. PMID: 1899430.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    348. Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies. J Clin Invest. 1989 Jul; 84(1):214-9. Wallis RS, Alde SL, Havlir DV, Amir-Tahmasseb MH, Daniel TM, Ellner JJ. PMID: 2500454.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    349. Do not resuscitate discussions in a hospital-based home care program. J Am Geriatr Soc. 1989 Jan; 37(1):52-4. Havlir D, Brown L, Rousseau GK. PMID: 2909605.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    350. Biochemical and clinical aspects of amyloidosis. West J Med. 1987 Jul; 147(1):65-70. Havlir D, Tierney LM. PMID: 3424807.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    351. A 32-year-old man with the acquired immunodeficiency syndrome and pneumococcal meningitis. West J Med. 1987 May; 146(5):618-9. Havlir DV, Witt MD, Sande M. PMID: 3590766.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    352. Nutritional status of the elderly in Palmares, Costa Rica. Arch Latinoam Nutr. 1983 Jun; 33(2):409-22. Havlir DV, Murillo S, Robles E, Trejos A, Mata L. PMID: 6673676.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    353. Typhoid fever. N Y State J Med. 1982 Dec; 82(13):1792, 1875. Brown T, Havlir D. PMID: 6961298.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Diane's Networks
    Concepts (773)
    Derived automatically from this person's publications.
    _
    Co-Authors (132)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _